Cargando…
Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis
Recent reports suggest that microRNAs (miRNAs) may serve as prognostic biomarkers in osteosarcoma. Due to osteosarcoma's early metastasis and poor prognosis, it is very important to find novel prognostic biomarkers for improving osteosarcoma's prognosis. Herein we propose a meta-analysis f...
Autores principales: | Luo, Huan, Wang, Peng, Ye, Hua, Shi, Jianxiang, Dai, Liping, Wang, Xiao, Song, Chunhua, Zhang, Jianying, Li, Jitian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431663/ https://www.ncbi.nlm.nih.gov/pubmed/32849795 http://dx.doi.org/10.3389/fgene.2020.00789 |
Ejemplares similares
-
Non-coding RNAs as potential biomarkers in osteosarcoma
por: Fan, Lijuan, et al.
Publicado: (2022) -
Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma
por: Li, Shuai, et al.
Publicado: (2016) -
MicroRNAs as clinical biomarkers?
por: Angelini, Timothy G., et al.
Publicado: (2015) -
Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
por: Yao, Yunjin, et al.
Publicado: (2021) -
Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019)